share_log

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $28

Benzinga ·  Oct 30, 2023 09:26

Barclays analyst Michael Leithead maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $31 to $28.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment